- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Perseus Proteomics Inc (4882)
Perseus Proteomics Inc stock price live, this page displays TYO 4882 stock exchange data. View the 4882 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Perseus Proteomics Inc real time stock price chart below.
What Is the Perseus Proteomics Inc Stock Price Today?
The Perseus Proteomics Inc stock price today is 407.00.
What Is the Stock Symbol for Perseus Proteomics Inc?
The stock symbol for Perseus Proteomics Inc is ""4882.""
What Stock Exchange Does Perseus Proteomics Inc Trade On?
Perseus Proteomics Inc is listed and trades on the Tokyo stock exchange.
Is Perseus Proteomics Inc a Good Stock to Buy?
Determining whether Perseus Proteomics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4882 quote. (ISIN: JP3836800007)
What Is the Perseus Proteomics Inc Stock Price Today?
The Perseus Proteomics Inc stock price today is 407.00.
What Is the Stock Symbol for Perseus Proteomics Inc?
The stock symbol for Perseus Proteomics Inc is ""4882.""
What Stock Exchange Does Perseus Proteomics Inc Trade On?
Perseus Proteomics Inc is listed and trades on the Tokyo stock exchange.
Is Perseus Proteomics Inc a Good Stock to Buy?
Determining whether Perseus Proteomics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4882 quote. (ISIN: JP3836800007)
Tokyo
Currency in JPY
407.00
-2.00(-0.49%)
Delayed Data·
Fair Value
An estimate of a Perseus Proteomics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
407.00
412.00
52 wk Range
355.00
1,113.00
4882 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 8 days
More Info
Fair Value
An estimate of a Perseus Proteomics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
407.00412.00
52 wk Range
355.001,113.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4882 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Perseus Proteomics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Perseus Proteomics Inc Company Profile
Perseus Proteomics Inc., a drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody sequencing, antibody protein production, and contract antibody research activities, as well as supply of antibody products. Its product pipeline includes PPMX-T001, an anti-hepatocarcinoma antibody; PPMX-T002, an anticancer drug; PPMX-T003, a drug for the treatment of adult T-cell; and PPMX-T004, an antibody drug conjugate. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
Compare 4882 to Peers and Sector
Metrics to compare | 4882 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4882PeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.7x | −6.0x | −0.5x | |
PEG Ratio | −0.21 | 0.00 | 0.00 | |
Price/Book | 4.2x | 6.1x | 2.6x | |
Price / LTM Sales | 50.3x | 32.5x | 3.3x | |
Upside (Analyst Target) | - | 61.0% | 42.8% | |
Fair Value Upside | Unlock | 13.4% | 6.5% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-14.21 / --
Revenue / Forecast
37.00M / --
People Also Watch
FAQ
What Stock Exchange Does Perseus Proteomics Trade On?
Perseus Proteomics is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Perseus Proteomics?
The stock symbol for Perseus Proteomics is "4882."
What Is the Perseus Proteomics Market Cap?
As of today, Perseus Proteomics market cap is 6.03B.
What Is Perseus Proteomics's Earnings Per Share (TTM)?
The Perseus Proteomics EPS (TTM) is -63.35.
When Is the Next Perseus Proteomics Earnings Date?
Perseus Proteomics will release its next earnings report on 13 Aug 2025.
From a Technical Analysis Perspective, Is 4882 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Perseus Proteomics Stock Split?
Perseus Proteomics has split 0 times.
How Many Employees Does Perseus Proteomics Have?
Perseus Proteomics has 32 employees.
What is the current trading status of Perseus Proteomics (4882)?
As of 06 Aug 2025, Perseus Proteomics (4882) is trading at a price of 407.00, with a previous close of 409.00. The stock has fluctuated within a day range of 407.00 to 412.00, while its 52-week range spans from 355.00 to 1,113.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.